Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.775 USD | +0.67% | -6.44% | -33.80% |
07/05 | Transcript : AbCellera Biologics Inc., Q1 2024 Earnings Call, May 07, 2024 | |
07/05 | AbCellera Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.80% | 1.1B | |
+57.51% | 59.34B | |
+43.17% | 40.24B | |
-5.22% | 39.88B | |
-5.56% | 28.55B | |
+15.38% | 27.26B | |
-21.08% | 19.23B | |
+33.28% | 12.61B | |
+2.26% | 12.49B | |
+25.79% | 12.28B |
- Stock Market
- Equities
- ABCL Stock
- News AbCellera Biologics Inc.
- AbCellera Biologics : Earnings Flash (ABCL) ABCELLERA BIOLOGICS Reports Q1 Revenue $203M, vs. Street Est of $199.4M